A direct-to-consumer (DTC) health and wellness brand specializing in non-invasive nasal and respiratory solutions has quickly gained traction since its launch in October 2023. The company markets a consumer-friendly electronic device, along with a suite of accessories, consumables, and a subscription service launched in early 2026. As of March 2026, the brand reported $3.36M in net sales and $506.6K EBITDA, boasting a 73% gross margin and 4.5-star average from over 1,800 customer reviews. With a 140K+ customer database, their primary target is the U.S. market, while planning for growth into European and other international regions. Customer acquisition is largely through paid digital advertising platforms. The brand's ecosystem includes a core wellness device, associated accessories, and a high-margin next-generation platform, which presents immediate growth potential. The recent introduction of a subscription model generated $6K in monthly recurring revenue, indicating robust demand for recurring revenue streams. Financial performance is underscored by strong unit economics, reflected in low return rates and significant repeat purchase rates. The streamlined supply chain uses outsourced manufacturing and 3PL logistics to handle global shipping. Founders are selling to focus on a new venture in a separate industry but promise a smooth handover with up to a month's transition support. Assets included in the business sale are comprehensive, ranging from digital storefronts and customer databases to advertising accounts and inventory. The business offers significant expansion opportunities in product lines, geographic markets, and channel strategies, presenting a worthwhile acquisition for interested buyers.